Biotechne share price

WebMar 31, 2024 · Currently, BIO-TECHNE Corp’s price-earnings ratio is 46.2. BIO-TECHNE Corp’s trailing 12-month revenue is $1.1 billion with a 23.4% profit margin. Year-over-year quarterly sales growth most recently was 0.9%. Analysts expect adjusted earnings to reach $2.013 per share for the current fiscal year. BIO-TECHNE Corp currently has a 0.4% ... WebApr 12, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. BIO-TECHNE Corp …

Bio-Techne Corporation (TECH) Stock Price, News, Quote

WebNov 18, 2024 · As of 18 November 2024, the price of Bio-Techne stock ws standing at $337.84 a share. If a 4-for-1 Bio-Techne stock split is performed today, the post-split … WebApr 10, 2024 · This rating is based on the ratio between the company's share price and the free cash flow per share generated by its activities, based on the past and analysts' estimates for the coming years. The lower the ratio, the better the rating. Yield "Yield" rating is based on the dividend relative to its share price ... income from stocks taxable https://cecassisi.com

TECH: Bio-Techne Corp Stock Price Quote - NASDAQ GS

WebMar 3, 2024 · Over the past six months, its share price has underperformed the S&P500 Index by-8.02%. As of the last closing price of $78.24, shares in BIO-TECHNE were … WebApr 6, 2024 · According to the issued ratings of 9 analysts in the last year, the consensus rating for Bio-Techne stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for TECH. The average twelve-month price prediction for Bio-Techne is $104.36 with a high price target of $120.00 and a low price target of $88.00. WebOn Tuesday morning 04/11/2024 the Bio-Techne Corp share started trading at the price of $0.00. Compared to the closing price on Monday 04/10/2024 on NAS of $75.19, this is a … income from stocks form

Can Bio-Techne (TECH) Stock Continue to Grow Earnings?

Category:State of Michigan Retirement System Increases Position in Bio-Techne …

Tags:Biotechne share price

Biotechne share price

TECH Bio-Techne Corp. Stock Price & News - WSJ

WebApr 6, 2024 · Get Bio-Techne Corp (TECH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Web18 hours ago · About Price to Free Cash Flow. The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or ...

Biotechne share price

Did you know?

WebApr 5, 2024 · Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus. Feb. 3, 2024 at 6:53 a.m. ET by Tomi Kilgore. WebDec 31, 2024 · Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell …

WebBio-Techne Corporation's (NASDAQ:TECH) recent US$602m market cap decline means a loss of US$6.2k for insiders who bought this year. Simply Wall St. Aug-30-22 07:00AM. … WebStock analysis for Bio-Techne Corp (TECH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

WebApr 11, 2024 · The company's stock saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$86.62 and falling to the lows of US$71.62. Some share price movements can give ... WebThe latest Bio-Techne Corp Ordinary USD0.01 share price. View recent trades and share price information for Bio-Techne Corp Ordinary USD0.01

WebApr 12, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. BIO-TECHNE Corp Stock Price History. BIO-TECHNE Corp’s price is currently up 9.48% so far this month. During the month of April, BIO-TECHNE Corp’s stock price has reached a high of $81.24 and a low ...

WebApr 14, 2024 · Finally, Royal Bank of Canada dropped their target price on shares of Bio-Techne from $89.00 to $88.00 and set a “sector perform” rating on the stock in a report … income from tpp is considered asWebConsensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months. Markets data provided … income from ticket salesWebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bio-Techne Corp’s P/E ratio is 45.86. income from unconsolidated investmentsWebApr 14, 2024 · The biotechnology company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.03). The company had revenue … income from the sale of personal assetsWebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … income fund americaWebApr 12, 2024 · The firm has a market cap of $12.24 billion, a PE ratio of 48.32, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Bio-Techne Co. has a 52-week low of $68.00 and a 52-week high of $108.19. income from trusts to beneficiaryWebDec 3, 2024 · This left a book value of Bio-Techne of $1.343 billion, or a per share value of $34.16 vs. $39.98, or almost a $6 per share difference. Please keep in mind this is not what I am suggesting the ... income from two states